Presentation is loading. Please wait.

Presentation is loading. Please wait.

Pathologic N1 non-small cell lung cancer: Correlation between pattern of lymphatic spread and prognosis  Alessandro Marra, MD, PhD, Ludger Hillejan, MD,

Published byCecil Ford Modified over 5 years ago

Similar presentations

Presentation on theme: "Pathologic N1 non-small cell lung cancer: Correlation between pattern of lymphatic spread and prognosis  Alessandro Marra, MD, PhD, Ludger Hillejan, MD,"— Presentation transcript:

1 Pathologic N1 non-small cell lung cancer: Correlation between pattern of lymphatic spread and prognosis  Alessandro Marra, MD, PhD, Ludger Hillejan, MD, George Zaboura, MD, Toshio Fujimoto, MD, Dieter Greschuchna, MD, Georgios Stamatis, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 125, Issue 3, Pages (March 2003) DOI: /mtc Copyright © 2003 American Association for Thoracic Surgery Terms and Conditions

2 Fig. 1 Correlation between the site of the primary tumor and the level of lymph node involvement (P =.000). The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /mtc ) Copyright © 2003 American Association for Thoracic Surgery Terms and Conditions

3 Fig. 2 Correlation between the histology of the primary tumor and the level of lymph node involvement (P =.027). The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /mtc ) Copyright © 2003 American Association for Thoracic Surgery Terms and Conditions

4 Fig. 3 Correlation between pT classification and the level of lymph node involvement (P =.014). The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /mtc ) Copyright © 2003 American Association for Thoracic Surgery Terms and Conditions

5 Fig. 4 Actuarial overall survival for 535 patients with pN1 NSCLC ( ). The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /mtc ) Copyright © 2003 American Association for Thoracic Surgery Terms and Conditions

6 Fig. 5 Survival curves of patients with N1 disease according to T classification: T1 (+), n = 67; T2 (open triangles), n = 287; T3 (filled triangles), n = 128; T4 (open circles), n = 53 (log-rank test, P =.0000). The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /mtc ) Copyright © 2003 American Association for Thoracic Surgery Terms and Conditions

7 Fig. 6 Survival curves of patients with N1 disease according to the level and type of lymph node involvement: N1d (+), n = 251; N1p (open triangles), n = 87; N1i (filled triangles), n = 76; Nih (open circles), n = 342 (log-rank test, P =.0184). The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /mtc ) Copyright © 2003 American Association for Thoracic Surgery Terms and Conditions

Download ppt "Pathologic N1 non-small cell lung cancer: Correlation between pattern of lymphatic spread and prognosis  Alessandro Marra, MD, PhD, Ludger Hillejan, MD,"

Similar presentations

The effect of inguinal lymphatic manipulation on regional lymph flow patterns Jeffrey R. Rubin, MD, Lisa B. Eberlin, MD Journal of Vascular Surgery Volume.

The effect of inguinal lymphatic manipulation on regional lymph flow patterns Jeffrey R. Rubin, MD, Lisa B. Eberlin, MD Journal of Vascular Surgery Volume.
Pathologic N1 non-small cell lung cancer: Correlation between pattern of lymphatic spread and prognosis Alessandro Marra, MD, PhD, Ludger Hillejan, MD,

Pathologic N1 non-small cell lung cancer: Correlation between pattern of lymphatic spread and prognosis Alessandro Marra, MD, PhD, Ludger Hillejan, MD,
Stephen R. Broderick, MD, MPHS 

Stephen R. Broderick, MD, MPHS 
Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.

Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.
Significance of the Number of Positive Lymph Nodes in Resected Non-small Cell Lung Cancer  Takayuki Fukui, MD, Shoichi Mori, MD, Kohei Yokoi, MD, Tetsuya.

Significance of the Number of Positive Lymph Nodes in Resected Non-small Cell Lung Cancer  Takayuki Fukui, MD, Shoichi Mori, MD, Kohei Yokoi, MD, Tetsuya.
Is lung cancer resection indicated in patients with idiopathic pulmonary fibrosis?  Atsushi Watanabe, MD, PhD, Tetsuya Higami, MD, PhD, Syunsuke Ohori,

Is lung cancer resection indicated in patients with idiopathic pulmonary fibrosis?  Atsushi Watanabe, MD, PhD, Tetsuya Higami, MD, PhD, Syunsuke Ohori,
Synchronous multiple primary lung cancer: An increasing clinical occurrence requiring multidisciplinary management  Delphine Trousse, MD, Fabrice Barlesi,

Synchronous multiple primary lung cancer: An increasing clinical occurrence requiring multidisciplinary management  Delphine Trousse, MD, Fabrice Barlesi,
Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer  Sai-Hong Ignatius Ou, MD, PhD, Jason.

Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer  Sai-Hong Ignatius Ou, MD, PhD, Jason.
Effect of tumor size on prognosis in patients with non–small cell lung cancer: The role of segmentectomy as a type of lesser resection  Morihito Okada,

Effect of tumor size on prognosis in patients with non–small cell lung cancer: The role of segmentectomy as a type of lesser resection  Morihito Okada,
Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer  Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.

Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer  Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.
Impact of tumor size on outcomes after anatomic lung resection for stage 1A non–small cell lung cancer based on the current staging system  Shamus R.

Impact of tumor size on outcomes after anatomic lung resection for stage 1A non–small cell lung cancer based on the current staging system  Shamus R.
Clinical Prognosis of Superior Versus Basal Segment Stage I Non-Small Cell Lung Cancer  Yoshinori Handa, MD, Yasuhiro Tsutani, MD, PhD, Norifumi Tsubokawa,

Clinical Prognosis of Superior Versus Basal Segment Stage I Non-Small Cell Lung Cancer  Yoshinori Handa, MD, Yasuhiro Tsutani, MD, PhD, Norifumi Tsubokawa,
Yih-Leong Chang, MD, Chen-Tu Wu, MD, Yung-Chie Lee, MD, PhD 

Yih-Leong Chang, MD, Chen-Tu Wu, MD, Yung-Chie Lee, MD, PhD 
Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.

Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.
Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer  Hong.

Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer  Hong.
Detection of circulating tumor cells in patients with non–small cell lung cancer undergoing lobectomy by video-assisted thoracic surgery: A potential.

Detection of circulating tumor cells in patients with non–small cell lung cancer undergoing lobectomy by video-assisted thoracic surgery: A potential.
Role of lymphatic invasion in the prognosis of patients with clinical node-negative and pathologic node-positive lung adenocarcinoma  Takahiro Mimae,

Role of lymphatic invasion in the prognosis of patients with clinical node-negative and pathologic node-positive lung adenocarcinoma  Takahiro Mimae,
Tumors of the esophagogastric junction

Tumors of the esophagogastric junction
Factors predictive of prognosis after esophagectomy for squamous cell cancer  Houhuai Li, MD, PhD, Qingzhen Zhang, Lin Xu, MD, Yijiang Chen, Yongxiang.

Factors predictive of prognosis after esophagectomy for squamous cell cancer  Houhuai Li, MD, PhD, Qingzhen Zhang, Lin Xu, MD, Yijiang Chen, Yongxiang.
Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer  Robert E. Merritt, MD, Chuong D. Hoang, MD,

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer  Robert E. Merritt, MD, Chuong D. Hoang, MD,

Similar presentations

Ads by Google